Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C040P.05
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg | C069P.05
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Brolucizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Aflibercept Biosimilar | C013P
Aflibercept Biosimilar. Zaltrap / Eylea biosimilar CHO stable cell line is available for licensing to manufacture the aflibercept biosimilar protein. The research grade aflibercept biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human...